Standard BioTools Inc reports results for the quarter ended in June - Earnings Summary

Standard BioTools

31/07/2024 22:02

* Standard BioTools Inc  LAB.OQ  reported a quarterly
adjusted
loss of 12 cents​​ per share for the quarter ended in June,
higher than the same quarter last year, when the company
reported EPS of -22 cents.  The mean expectation of
three analysts for the quarter was for a loss of 9 cents per
share. Wall Street expected results to range from -10 cents
to -9 cents per share.
    * Revenue rose 35.4% to $37.21 million from a year ago;
analysts
expected $48.25 million. 
    * Standard BioTools Inc's reported EPS for the quarter was a
loss
of 12 cents​.
    * The company reported a quarterly loss of $45.72 million.
    * Standard BioTools Inc shares had risen by 31.1% this
quarter and
gained 5.0% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 9.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is  "buy."

Wall Street's median 12-month price target for Standard BioTools
Inc is $3.50 
This summary was machine generated from LSEG data July 31 at
09:01 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.09          -0.12          Missed
 Mar. 31 2024      -0.12          -0.27          Missed
 Dec. 31 2023      -0.13          -0.25          Missed
 Sep. 30 2023      -0.12          -0.27          Missed